The prevalence and prognostic value of KRAS co‐mutation subtypes in Chinese advanced non‐small cell lung cancer patients

OBJECTIVE: KRAS mutation plays a critical role in the initiation and development of non‐small cell lung cancer (NSCLC). KRAS‐mutant patients exhibit diverse response to chemotherapy. KRAS co‐mutation subtypes and their prognosis value in advanced Chinese NSCLC patients remain largely elusive. METHOD...

Descripción completa

Detalles Bibliográficos
Autores principales: Cai, Dongjing, Hu, Chengping, Li, Li, Deng, Shichao, Yang, Jing, Han‐Zhang, Han, Li, Min
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Clinical Cancer Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6943152/
https://www.ncbi.nlm.nih.gov/pubmed/31709742
http://dx.doi.org/10.1002/cam4.2682

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6943152/
https://www.ncbi.nlm.nih.gov/pubmed/31709742
http://dx.doi.org/10.1002/cam4.2682

Ejemplares similares